Abbott on March 11 announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
Study: Regeneron COVID-19 drug cocktail combats South Africa variant, Lilly’s does notBamlanivimab (LY-CoV555), Britain, Columbia University, COVID-19 Antibodies, Covid-19 Variants, Eli Lilly, GlaxoSmithKline, National Institutes of Health, Papers, Regeneron Pharmaceuticals, South Africa, Testing Labs, Vir Biotechnology
Laboratory testing found that Regeneron Pharmaceuticals Inc.’s Covid-19 antibody cocktail can combat a coronavirus variant first found in South Africa, but a similar drug from Eli Lilly and Co. is inactive against it, according to a study.
FDA Approves Roche Covid-19 Test that Aims to Test Vaccines’ Antibody ResponseAntibody Response, Blood, Blood Samples, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Antibodies, COVID-19 Testing, CoVIg-19 Plasma Alliance, Emergency Use Authorization, FDA, Moderna, Pfizer, SARS-CoV-2 spike protein, Testing Labs
The U.S. Food and Drug Administration gave Emergency Use Authorization (EUA) to a Covid-19 test developed by Roche that measures antibodies within the blood.
Qiagen readies launch of rapid COVID-19 antigen test (Reuters) – German diagnostic test maker Qiagen on Tuesday said it planned to launch a COVID-19 antigen test that can provide results […]
Antibody levels against the novel coronavirus rose and then held steady for up to four months in more than 90% of recovered Covid-19 patients in Iceland, according to a published study.
Researchers are developing simpler Covid-19 diagnostic tests for use outside of labs in an effort to make mass testing available, fast and inexpensive.
The National Institutes of Health is investing $248.7 million in seven diagnostic companies with new testing technologies to increase their testing capacities and make millions of rapid Covid-19 tests per week available by fall.
White Paper: Consistent Terms for Testing in Precision MedicineAmerican Society of Clinical Oncology (ASCO), Biomarkers, Biotech, Cancer, Diagnostics, Genetic Testing, Hematologic malignancies, Inherited Mutations, Medical Societies, Patient Advocates, Patient Education, Pharma, Precision Medicine, Solid Tumors, Testing Labs, White Papers
The Consistent Testing Terminology Working Group published a white paper with industry-wide recommendations for precision medicine testing terms to be utilized in patient education and communication.
In a BioSpace interview, Sorrento Therapeutics executives emphasized the stringent process the company went through in identifying the antibody STI-1499, which demonstrated 100 percent inhibition of SARS-CoV-2 in laboratory tests.
In the company’s daily blog about the precautions being taken to ensure continued service to the world, Amazon intends to build testing facilities for employees.